Showing results (581-590 of 637) with videos related to

Sort By:
Pageof 64
Health Education Quarterly|January 1, 1989
A family approach to cardiovascular risk reduction: results from the San Diego Family Health ProjectP R Nader, J F Sallis, T L Patterson, et al.
Bioorganic & Medicinal Chemistry|January 8, 2014
Retinoic acid signaling pathways in development and diseasesBhaskar C Das, Pritam Thapa, Radha Karki, et al.
British Journal of Haematology|October 18, 2005
Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genesN Porakishvili, N Kulikova, A P Jewell, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Ciliogenesis associated kinase 1 accumulates in its inactive form during polycystic kidney disease progressionAlice Serafin, Charlène Coquil, Aurore Dupuy, et al.
Health Technology Assessment (Winchester, England)|November 18, 2004
Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultationsP Wallace, J Barber, W Clayton, et al.
Radiology|January 31, 2014
Comparison of two-dimensional synthesized mammograms versus original digital mammograms alone and in combination with tomosynthesis imagesMargarita L Zuley, Ben Guo, Victor J Catullo, et al.
Journal of Digital Imaging|May 20, 2006
A multisite telemammography system for remote management of screening mammography: an assessment of technical, operational, and clinical issuesJoseph K Leader, Christiane M Hakim, Marie A Ganott, et al.
Soil Use and Management|September 27, 2016
A review of the impacts of degradation threats on soil properties in the UKA S Gregory, K Ritz, S P McGrath, et al.
American Journal of Physiology. Renal Physiology|August 18, 2022
The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney diseaseShirin V Sundar, Julie Xia Zhou, Brenda S Magenheimer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2001
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neuT Schwaab, L D Lewis, B F Cole, et al.
Pageof 64